John Hohneker
Fortune : - $ au 31/07/2026
Fortune : - $ au 31/07/2026
Dr. John A. Hohneker, MD, is an Independent Director at Arrivent BioPharma, Inc. and an Independent Director at Curis, Inc. He is on the Board of Directors at Artios Pharma Ltd., Arrivent BioPharma, Inc., Curis, Inc. and Trishula Therapeutics, Inc. Dr. Hohneker was previously employed as an Independent Director by Carisma Therapeutics, Inc., an Independent Director by Humanigen, Inc., an Independent Director by Aravive, Inc., an Independent Director by Evelo Biosciences, Inc., a President, Chief Executive Officer & Director by Anokion SA, a Head-Research & Development by Forma Therapeutics, Inc., a Senior Vice President by Novartis Pharmaceuticals Corp., a Senior Vice President & Global Head-Development by Novartis AG, and a Chief Executive Officer by Kanyos Bio, Inc. He also served on the board at BioTheryX, Inc., Sonata Therapeutics, Inc., Torque Therapeutics, Inc., Dimension Therapeutics, Inc. and Cygnal Therapeutics, Inc. He received his undergraduate degree from Gettysburg College, a doctorate degree from Robert Wood Johnson Medical School and a doctorate degree from the University of Medicine & Dentistry of New Jersey.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CURIS, INC. -.--% | 07/07/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| 31/05/2025 | 0 ( -.--% ) | - $ | 30/06/2026 | |
| 18/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CURIS, INC. | Directeur/Membre du Conseil | 02/12/2021 |
| ARRIVENT BIOPHARMA, INC. | Directeur/Membre du Conseil | 16/05/2024 |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Directeur/Membre du Conseil | 01/09/2024 |
Trishula Therapeutics, Inc.
Trishula Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cancer curing drugs and antibiotics | Directeur/Membre du Conseil | 01/09/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 15/10/2025 |
Sonata Therapeutics, Inc.
Sonata Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics and novel medicines | Directeur/Membre du Conseil | - |
| ARAVIVE, INC. | Directeur/Membre du Conseil | 17/01/2024 |
| HUMANIGEN, INC. | Directeur/Membre du Conseil | 18/07/2023 |
| EVELO BIOSCIENCES, INC. | Directeur/Membre du Conseil | 11/07/2023 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 21 |
|---|---|
Curis, Inc.
Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Humanigen, Inc.
Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
Forma Therapeutics, Inc.
Forma Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer and other genetically driven diseases | Health Technology |
BioTheryX, Inc.
BioTheryX, Inc. Packaged SoftwareTechnology Services Operates as a biopharmaceutical company that develops protein degradation platform | Technology Services |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Medicine & Dentistry of New Jersey
University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gettysburg College
Gettysburg College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Robert Wood Johnson Medical School
Robert Wood Johnson Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dimension Therapeutics, Inc.
Dimension Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for rare diseases | Health Technology |
Anokion SA
Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance | Health Technology |
Kanyos Bio, Inc.
Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for type 1 diabetes | Health Technology |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies to address cancers | Health Technology |
Evelo Biosciences, Inc.
Evelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for small intestine related diseases | Health Technology |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Health Technology |
Cygnal Therapeutics, Inc.
Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops drugs for treatments of cancer, immune-inflammatory disorders, fibrotic and degenerative diseases | Health Technology |
Aravive, Inc.
Aravive, Inc. BiotechnologyHealth Technology Develops therapies for solid tumors and hematologic malignancies | Health Technology |
Trishula Therapeutics, Inc.
Trishula Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cancer curing drugs and antibiotics | Health Technology |
Arrivent BioPharma, Inc.
Arrivent BioPharma, Inc. Pharmaceuticals: OtherHealth Technology Engages in development and commercialization of cancer medicines | Health Technology |
Sonata Therapeutics, Inc.
Sonata Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics and novel medicines | Health Technology |
Carisma Therapeutics, Inc.
Carisma Therapeutics, Inc. BiotechnologyHealth Technology Develops novel chimeric antigen receptor macrophage and CAR-monocyte technology treatment of non-muscle invasive bladder cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national